THE following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.
Omicron infections no less severe based on early UK data
Infections caused by the Omicron variant of the coronavirus do not appear to be less severe than infections from Delta, according to early data from the UK.
Researchers at Imperial College London compared 11,329 people with confirmed or likely Omicron infections with nearly 200,000 people infected with other variants.
So far, according to a report issued ahead of peer review and updated on Monday, they see "no evidence of Omicron having lower severity than Delta, judged by either the proportion of people testing positive who report symptoms, or by the proportion of cases seeking hospital care after infection."
For vaccines available in the UK, effectiveness against symptomatic Omicron infection ranged from 0% to 20% after two doses, and from 55% to 80% following a booster dose.
The report also estimated that after taking individual risk factors into account, the odds of reinfection with Omicron are 5.4 times greater than for reinfection with Delta.
A study of healthcare workers in the pre-Omicron era estimated that a prior SARS-CoV-2 infection afforded 85% protection against a second infection over 6 months, the researchers said, while "the protection against reinfection by Omicron afforded by past infection may be as low as 19%."
Sperm count, motility may be low for months after COVID-19
Sperm quality is impaired for months for some people after recovery from COVID-19, researchers have found.
The semen itself was not infectious, the researchers found. But among 35 men who provided samples within a month after recovery from symptomatic infection, reductions in sperm motility were evident in 60% and sperm counts were reduced in 37%. As reported on Monday in Fertility and Sterility, semen samples were obtained from 120 Belgian men with an average age of 35 years, at an average of 52 days after their COVID-19 symptoms had resolved.
Among 51 men tested between one and two months after recovery, 37% had reduced sperm motility and 29% had low sperm counts. Among 34 men who provided semen samples at least two months after recovery, sperm motility was impaired in 28% and sperm counts were low in 6%. The severity of COVID-19 infection was not correlated with sperm characteristics.
"Couples with a desire for pregnancy should be warned that sperm quality after COVID-19 infection can be suboptimal," the researchers concluded. "The estimated recovery time is 3 months, but further follow-up studies are under way to confirm this and to determine if permanent damage occurred in a minority of men."
Neutralizing molecule could be cheaper than antibodies
An experimental molecule that neutralizes the coronavirus in the same way antibodies do would be cheaper and easier to manufacture, researchers said.
The molecule belongs to a class of compounds known as aptamers. Because they are made from RNA or DNA, aptamers are easier to synthesize than protein-based antibodies that can only be produced in living cells, said Julian Valero of Aarhus University in Denmark.
Like antibodies, the aptamers attach themselves to protein targets - in this case, the spike protein on the virus surface - by folding into a three-dimensional conformation.
A study published in PNAS shows that in test tube experiments, the aptamer binds tightly to the coronavirus spike, preventing it from breaking into human cells. It inhibits earlier variants of the virus, including Delta, the researchers said. They are planning tests to see whether it also recognizes and binds to Omicron.
Use of the aptamer in patients is still far off, with tests in mice only recently begun. In terms of use in humans, "we're much closer" to being able to use the aptamer to help diagnose SARS-CoV-2 infections, said Jorgen Kjemsa, also of Aarhus University. Experiments comparing the use of the aptamer to antibodies in widely used rapid COVID-19 tests for infection are underway, he said.
Reuters
Tue Dec 21 2021
People queue to be tested for COVID-19 in Times Square, as the Omicron coronavirus variant continues to spread in Manhattan, New York City, U.S., December 20, 2021. - REUTERS
Usia Persaraan: KWSP disaran sediakan pinjaman untuk akaun 1 penyimpang
KWSP disaran untuk lebih kreatif bagi membantu penyimpan capai jumlah ideal untuk zaman persaraan, iaitu sekitar RM240,000.
Penganalisis Ekonomi Dr Barjoyai Bardai mencadangkan KWSP pertimbang beri pinjaman untuk akaun 1, dengan syarat ia tidak boleh diganggu.
#AWANI745
Penganalisis Ekonomi Dr Barjoyai Bardai mencadangkan KWSP pertimbang beri pinjaman untuk akaun 1, dengan syarat ia tidak boleh diganggu.
#AWANI745
MoF tiada rekod surat kelulusan Najib
Mahkamah Tinggi Kuala Lumpur diberitahu, Kementerian Kewangan tidak mempunyai pengetahuan mengenai dua surat kelulusan yang ditandatangani oleh Datuk Seri Najib Tun Razak selaku Menteri Kewangan.
#AWANI745
#AWANI745
Kes saman Ahmad Zahid terhadap Muhyiddin selesai secara baik
Kes saman yang difailkan Timbalan Perdana Menteri Datuk Seri Ahmad Zahid Hamidi terhadap bekas Perdana Menteri Tan Sri Muhyiddin Yassin, selesai secara baik di Mahkamah Tinggi hari ini.
AWANI Borneo [26/04/2024] - Permintaan terkahir Joanna | Cakna kepentingan pertahanan | Jangan takut ugutan
Laporan berita padat dan ringkas dari Borneo bersama Nickyson Nyambar;
#AWANIBorneo 26 April 2024
Suami mendiang Joanna dedah hasrat isteri untuk Gawai ini
Sarawak berpotensi jadi pemain industri pertahanan negara
Jangan berdiam, Armizan minta pemilik syarikat minyak lapor jika terima ugutan
#AWANInews
#AWANIBorneo 26 April 2024
Suami mendiang Joanna dedah hasrat isteri untuk Gawai ini
Sarawak berpotensi jadi pemain industri pertahanan negara
Jangan berdiam, Armizan minta pemilik syarikat minyak lapor jika terima ugutan
#AWANInews
Gelombang haba bawa derita baharu, risiko penyakit ke Gaza
Peningkatan suhu melampau luar jangka di seluruh Gaza menambah derita yang dihadapi warga Palestin setiap hari di semenanjung itu.
Tarikh akhir pengemukaan Borang E dan CP8D dilanjutkan hingga 31 Mei
Lembaga Hasil Dalam Negeri (LHDN) hari ini memaklumkan tarikh akhir pengemukaan Borang E dan C.P.8D dilanjutkan hingga 31 Mei ini.
Freedom Flotilla to Gaza: AS terus beri tekanan kepada Turki
AS yang merupakan rakan sekutu Israel dilaporkan terus memberi tekanan yang hebat kepada Turki untuk tidak memberi kebenaran pelayaran misi Break The Siege Freedom Flotilla to Gaza.
Rumah terbuka himpunkan penduduk pelbagai kaum Kinabatangan
Sekitar 3,000 pengunjung daripada pelbagai kaum dan agama menghadiri rumah terbuka aidilfitri daerah Kinabatangan.
#AWANIBorneo
#AWANIBorneo
Enam inisiatif kekalkan momentum pertumbuhan Labuan IBFC 2024
Ketua Pengarah Lembaga Perkhidmatan Kewangan Labuan (Labuan FSA) Nik Mohamed Din Nik Musa berkata inisiatif ini penting dalam merangka hala tuju Labuan IBFC ketika Pelan Hala Tuju Strategik Lima tahunnya (2022-2026) memasuki tahun ketiga.
#AWANIBorneo
#AWANIBorneo
Sindiket ancam bakar stesen minyak harus dilaporkan - Armizan
Pemilik stesen minyak yang diancam sindiket penyeludupan diesel bersubsidi disaran membuat laporan secara rasmi kepada Kementerian Perdagangan Dalam Negeri dan Kos Sara Hidup (KPDN), kata Menterinya Datuk Armizan Mohd Ali.
#AWANIBorneo
#AWANIBorneo
COVID-19 terkawal tetapi virus akan terus ada bersama kita - KKM
Kebanyakan kes COVID-19 yang dilaporkan mengalami gejala ringan dan tidak memerlukan rawatan di hospital.
COVID-19: Kes aktif varian Omicron bergejala ringan - Pakar perubatan
Beliau berkata kes COVID-19 dijangka berkurangan selepas satu bulan berdasarkan pemerhatian trend jangkitan virus oleh KKM.
COVID-19: Kes meningkat kepada 12,757 pada ME49/2023
Walaupun terdapat peningkatan kes COVID-19, keadaan di Malaysia masih terkawal dan tidak membebankan fasiliti kesihatan sedia ada.
COVID-19: Kes jangkitan meningkat kepada 2,305 minggu lalu, 21 varian Omicron
Daripada jumlah itu, terdapat 20 kes Variant of Concern (VOC) dan satu kes Variant of Interest (VOI).
COVID-19: Qatar kesan kes pertama varian baharu EG.5
Qatar mengesan kes pertama varian baharu COVID-19 dikenali EG.5 di negara itu, kata Kementerian Kesihatan Awam pada Khamis.
Saintis seru rakyat UK pakai pelitup muka ekoran varian baharu "Eris"
Saintis menggesa orang ramai di United Kingdom kembali memakai pelitup muka di tengah-tengah kebimbangan "mutasi" subvarian Omicron, "Eris" yang kini menyumbang satu daripada 10 kes di negara itu.
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah yang paling menjadi tumpuan sepanjang Selasa, 18 April 2023.
COVID-19: Indonesia kesan tujuh kes Arcturus setakat ini
Indonesia mengesan lima kes baharu subvarian Omicron, Arcturus, menjadikan jumlah keseluruhan kepada tujuh kes setakat semalam.
Kes COVID-19 dalam negara masih terkawal - Dr Zaliha
Kes COVID-19 di dalam negara ini masih lagi terkawal meskipun berlaku sedikit peningkatan kebelakangan ini dan rakyat tidak perlu panik, kata Menteri Kesihatan Dr Zaliha Mustafa.
Vaksin COVID-19: Australia lancar dos penggalak kelima
Keputusan itu memperluaskan kelayakan suntikan dos penggalak merangkumi kira-kira 14 juta orang yang akan ditawarkan vaksin.